Ignite Creation Date:
2024-05-06 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05317078
Status:
TERMINATED
Last Update Posted:
2024-07-08
First Post:
2022-03-30
Brief Title:
A Phase 1 Safety Tolerability and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer Epithelial Ovarian Cancer and Other Malignant Solid Tumor Indications
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20210007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None